| IPI00199035 - Pten, ADVANCED CANCERS PROTEIN. | |
|---|---|
| Uniprot Accession: Q812B9 | |
| Uniprot ID: Q812B9_RAT | |
| Mapping: Chr 1, 236771027 - 236837261 | |
| Entrez Gene: 50557 | |
| Entrez MapView: |
|
| RGD: 61995 | |
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_1409) |
|---|
| Rat: Pten, ADVANCED CANCERS PROTEIN. |
| Mouse: Pten, PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE 3-PHOSPHATASE PTEN. |
| Mouse: Pten, SEQUENCE. |
| Human: PTEN, SPECIFICITY PROTEIN PHOSPHATASE PTEN. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cytoplasm | C | IDA TAS | ||
| PDZ domain binding | F | IPI IPI | ||
| protein binding | F | IPI IPI IPI | IPI | |
| protein serine/threonine phosphatase activity | F | IDA | ||
| phosphoric monoester hydrolase activity | F | IEA | IEA | |
| inositol or phosphatidylinositol phosphatase activity | F | ISS | ||
| platelet-derived growth factor receptor binding | F | IDA | ||
| lipid binding | F | IEA | ||
| phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity | F | IDA | ||
| hydrolase activity | F | IEA | IEA | IEA |
| inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity | F | IDA | ||
| phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity | F | IDA IDA | IDA | ISS |
| protein tyrosine phosphatase activity | F | IDA | ||
| protein tyrosine/serine/threonine phosphatase activity | F | IEA | IEA | TAS IEA |
| phosphatidylinositol-3-phosphatase activity | F | IDA | ||
| negative regulation of cell proliferation | P | IMP | IGI IMP | IDA |
| phosphoinositide dephosphorylation | P | IDA IDA | ||
| inositol phosphate dephosphorylation | P | IDA | ISS | |
| platelet-derived growth factor receptor signaling pathway | P | IDA | ||
| endothelial cell migration | P | IEA | IMP | |
| lipid metabolic process | P | IEA | ||
| dephosphorylation | P | IEA | ||
| negative regulation of progression through cell cycle | P | IEA | IEA | |
| protein amino acid dephosphorylation | P | IDA TAS | IEA | IEA |
| negative regulation of apoptosis | P | IEA | IMP | |
| regulation of protein stability | P | IMP | ||
| cell proliferation | P | TAS | ||
| regulation of cyclin-dependent protein kinase activity | P | TAS | ||
| negative regulation of protein kinase B signaling cascade | P | IMP | IMP | |
| negative regulation of cell migration | P | IMP | TAS | |
| central nervous system development | P | ISS | IMP | ISS |
| angiogenesis | P | IEA | IMP | |
| cell cycle | P | IEA | IEA | |
| induction of apoptosis | P | ISS | IMP | TAS ISS |
| negative regulation of focal adhesion formation | P | IMP | ||
| heart development | P | ISS | IMP | ISS |
| neurite development | P | IDA | ||
| cell migration | P | IMP | ISS | |
| cardiac muscle development | P | IEA | IMP |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| skin/coat/nails phenotype | MP | Un | ||
| craniofacial phenotype | MP | Un | ||
| adipose tissue phenotype | MP | Un | ||
| behavior/neurological phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| endocrine/exocrine gland phenotype | MP | Un Un Un Un | ||
| growth/size phenotype | MP | Un Un | ||
| immune system phenotype | MP | Un Un Un | ||
| embryogenesis phenotype | MP | Un Un Un | ||
| lethality-embryonic/perinatal | MP | Un Un Un Un Un Un | ||
| life span-post-weaning/aging | MP | Un Un Un | ||
| reproductive system phenotype | MP | Un Un Un Un Un | ||
| muscle phenotype | MP | Un | ||
| renal/urinary system phenotype | MP | Un | ||
| nervous system phenotype | MP | Un Un Un | ||
| hematopoietic system phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un Un Un | ||
| normal phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un Un | ||
| tumorigenesis | MP | Un Un Un Un Un Un | ||
| epidermal hyperplasia | N | ISS | ||
| abnormal brain development | N | ISS | ||
| embryonic growth arrest | N | ISS | ||
| seizures | N | ISS | ||
| embryonic lethality | N | ISS | ||
| fatty liver | N | ISS | ||
| skin hyperplasia | N | ISS | ||
| prostate gland hyperplasia | N | ISS | ||
| resistance to tumor development | N | ISS | ||
| enlarged liver | N | ISS | ||
| decreased cardiac muscle contractility | N | ISS | ||
| ataxia | N | ISS | ||
| cardiac hypertrophy | N | ISS | ||
| increased B cell proliferation | N | ISS |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Hypertrophy, Left Ventricular | D | IED | ||
| Cardiomegaly | D | ISS | ||
| Hypertension, Portal | D | IED |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| inositol phosphate metabolic pathway | W | IEA | ||
| phosphatidylinositol 3 kinase-Akt signaling pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glioma (05214) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Tight junction (04530) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Inositol phosphate metabolism (00562) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Focal adhesion (04510) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Phosphatidylinositol signaling system (04070) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |